News – Page 565 – Endpoints News

Pharma colors and marketing: Typically ‘awash in blue,’ newer brand updates adopt bold hues

4 years ago

'Test to treat': Biden launches new Covid pill initiative amid outstanding questions on access

4 years ago

Kurma scores $175M in first closing of biotech/healthtech fund — the VC's largest yet

4 years ago

Sherlock, Feng Zhang's CRISPR diagnostic outfit, grabs $80M to go beyond Covid-19

4 years ago

BioNTech and Regeneron expand their cancer partnership, pushing new Libtayo combo into NSCLC

4 years ago

‘We would have no choice’: Biogen CEO Vounatsos isn’t about to let go of the budget axe — unless they break ...

4 years ago

With investment from Alloy, Boston peptide manufacturer announces Series A

4 years ago

Overhauling FDA's accelerated approval pathway: Key House committee chair pens new bill

4 years ago

An AI biotech emerges from stealth promising drugs 'on demand.' What will that look like, and is it even possible?

4 years ago

Novartis takes a gamble on Voyager's new AAV tech, inks $1.7B gene therapy discovery pact

4 years ago

So, just how much are those CRISPR patents actually worth?

4 years ago

After nearly two years of criticism from activists and White House, Moderna unveils a new plan for global health

4 years ago

J&J regrets paying for study that injected incarcerated Black men with asbestos — report

4 years ago

Months after big financing round, Touchlight signs supply agreement for Versameb's pipeline

4 years ago

Big Pharma veteran Karin Shanahan reunites with Bristol Myers' supply team after 12 years apart

4 years ago

After 16 years, BMS' megablockbuster cancer drug finally runs into its first generic competition

4 years ago

Endo’s first DTC campaign for Qwo tackles cellulite by encouraging women to think ‘Butt First’

4 years ago

Digital tech boosted Pfizer commercial, R&D gains during Covid — and there’s no going back, execs say

4 years ago

Real world data and FDA: Drugmakers seek more clarity on registry guidance

4 years ago

Kenya wins $500M sweepstakes for Moderna's first African manufacturing site

4 years ago

GSK chief Emma Walmsley made $10.8M last year, lagging far behind fellow Big Pharma CEOs

4 years ago

John Maraganore joins up with ProQR as strategic advisor; Servier nabs priority review for Tibsovo sNDA

4 years ago

Looking to push checkpoint efficacy, a quiet microbiome upstart bags $67M for clinical work

4 years ago

Nasal spray maker clinches first PhIII win it needs to reach a much, much bigger market

4 years ago

First page Previous page 562 563 564565566 567 568 Next page Last page